Abstract:Background: Accumulating evidence indicates that Nicotinamide N-methyltransferase (NNMT) is abnormally expressed in tumor tissues of several cancers including colorectal cancer (CRC) and associated with cancer progression. However, the distribution characteristics and the clinical value of each part of NNMT expression in CRC are still not fully understood. The purpose of this study is to determine the distribution of NNMT expression and its association with survival in CRC.Methods: By using the cancer genome atlas (TCGA) and clinical proteomic tumor analysis consortium (CPTAC), we firstly analyzed the difference of gene and protein levels of NNMT between CRC and normal colorectal tissue. Then, NN MT protein expressions were detected in 18 intraepithelial neoplastic samples and 177 CRC tumor samples through immunohistochemistry in our study cohort. Furthermore, the relationship between NNMT expression and clinicopathological characteristics, overall survival (OS) and disease-free survival (DFS) of CRC patients were analyzed by Pearson chi(2) test and log-rank test, respectively, in public datasets and our study cohort. Lastly, the function of NNMT and its product 1-methyl-nicotinamide (1-MNA) on migration and invasion in colorectal cancer cells was analyzed by wound healing assay and transwell assay.Results: We determined that higher NNMT expression in CRC tissues than normal tissues in both gene and protein level in TCGA and CPTAC datasets (all p < 0.05). In addition, the strong relationships of NNMT expression with stromal cells were found in the TCGA cohort. Fortunately, our cohort could validate that the expression of NNMT in tumor stroma cell was significantly higher than that in tumor cell (p < 0.0001), and both of them were significantly higher than that in adjacent normal tissue (ANT) (p < 0.0001 and p < 0.0001, respectively). Furthermore, the positive NNMT expression in tumor cell and stromal cell were associated with series of unfavorable clinical characteristics, including advanced TNM stage, lymph node metastasis, distant metastasis (all p < 0.05). Also, higher NNMT was associated with unfavorable survival both in our study and public datasets, including TCGA and two Gene Expression Omnibus (GEO) datasets (GSE33113 and GSE17538). Moreover, the functional experiments showed that stromal cells with high NNMT expression can secret 1-MAN to promote migration and invasion of CRC cells in vitro.Conclusions: In CRC, NNMT is overexpressed in tumor cells and stroma cells, and then mainly expressed in tumor stroma cells. Overexpression of NNMT in tumor cell and stroma cell both are associated with metastasis and unfavorable survival. Besides, stromal cells with high NNMT expression secrets 1-MAN to promote migration and invasion of CRC cells. Therefore, NNMT may be a potential prognostic indicator in CRC patients.

Enhanced Nuclear Translation is Associated with Proliferation and Progression Across Multiple Cancers

Nicotinamide N-methyltransferase Enhances the Capacity of Tumorigenesis Associated with the Promotion of Cell Cycle Progression in Human Colorectal Cancer Cells.

NNMT contributes to high metastasis of triple negative breast cancer by enhancing PP2A/MEK/ERK/c-Jun/ABCA1 pathway mediated membrane fluidity.

Nicotinamide N -methyltransferase enhances chemoresistance in breast cancer through SIRT1 protein stabilization

Overexpression Of Nicotinamide N-Methyltransferase Mainly Covers Stroma Of Colorectal Cancer And Correlates With Unfavorable Survival By Its Product 1-Mna

The Regulation of Protein Translation and Its Implications for Cancer

Nucleoporin TPR Promotes Trna Nuclear Export and Protein Synthesis in Lung Cancer Cells.

NMT1 Enhances the Stemness of NSCLC Cells by Activating the PI3K/AKT Pathway

TNNT1 Facilitates Proliferation of Breast Cancer Cells by Promoting G1/S Phase Transition.

Nicotinamide Nucleotide Transhydrogenase-Mediated Redox Homeostasis Promotes Tumor Growth and Metastasis in Gastric Cancer

Ribosome ADP-ribosylation inhibits translation and maintains proteostasis in cancers

Overexpression of NNMT in Glioma Aggravates Tumor Cell Progression: an Emerging Therapeutic Target.

Mutual dependency between lncRNA LETN and protein NPM1 in controlling the nucleolar structure and functions sustaining cell proliferation

Novel INHAT Repressor Drives Glioblastoma Growth by Promoting Ribosomal DNA Transcription in Glioma Stem Cells

The m5 C methyltransferase NSUN2 promotes codon-dependent oncogenic translation by stabilising tRNA in anaplastic thyroid cancer

Nucleolin malonylation as a nuclear-cytosol signal exchange mechanism to drive cell proliferation in Hepatocarcinoma by enhancing AKT translation

The Potential of Nuclear Pore Complexes in Cancer Therapy

RNPS1 Stabilizes NAT10 Protein to Facilitate Translation in Cancer Via Trna Ac4c Modification

Nup210 Promotes Colorectal Cancer Progression by Regulating Nuclear Plasma Transport

HNRNPU Promotes the Progression of Triple-Negative Breast Cancer Via RNA Transcription and Alternative Splicing Mechanisms.

Nucleolin acute degradation reveals novel functions in cell cycle progression and division in TNBC